摘要
目的探讨糖链抗原19-9(CA19-9)在卵巢成熟畸胎瘤诊断中的价值。方法选取2012年12月至2015年12月在陕西中医药大学第二附属医院妇科进行手术的卵巢成熟畸胎瘤患者160例,于术前检查包括CA19-9在内的4种肿瘤标志物,并对相关数据进行分析。结果在4种肿瘤标志物中,CA19-9的阳性率最高,占38.75%(62/160);CA19-9升高组肿瘤直径较CAl9-9正常组直径明显增大,差异有统计学意义(t=2.378,P<0.05);双侧卵巢均存在畸胎瘤时CA19-9水平较仅单侧卵巢存在畸胎瘤明显升高,差异有统计学意义(t=2.226,P<0.05)。结论 CA19-9在卵巢成熟畸胎瘤的诊断与鉴别诊断中具有一定的临床意义。
Objective To explore the diagnostic value of CA19-9 in mature ovarian teratoma. Methods Totally 160 patients undergoing surgery for mature ovarian teratoma in the Second Affiliated Hospital of Shaanxi University of Chinese Medicine between December 2012 and December 2015 were selected, and the levels of four tumor markers including CA19-9 were studied before operation. Results Among four tumor markers, the positive rate of CA19-9 was highest （38.75% , 62/160）. The mean tumor size of patients with elevated CA19-9 level was significantly greater than those with normal CA19-9 level （ t = 2. 378, P 〈 0.05 ）. Patients with bilateral teratomas showed a significantly higher CA19-9 level than those with unilateral ones （t = 2. 226, P 〈 0.05 ）. Conclusion CA19-9 shows clinical significance in diagnosis and differential diagnosis of mature ovarian teratoma.
出处
《中国妇幼健康研究》
2016年第9期1063-1065,共3页
Chinese Journal of Woman and Child Health Research
